{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T14:10:27Z","timestamp":1795183827855,"version":"4.10.3"},"reference-count":62,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T00:00:00Z","timestamp":1689206400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.cmi.2023.07.003","type":"journal-article","created":{"date-parts":[[2023,7,6]],"date-time":"2023-07-06T12:48:49Z","timestamp":1688647729000},"page":"1375-1384","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Risk of progression to active tuberculosis for indeterminate interferon-gamma release assay in immunocompromised individuals: a systematic review and meta-analysis"],"prefix":"10.1016","volume":"29","author":[{"given":"Guozhong","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiqi","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunli","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2023.07.003_bib1","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00655-2019","article-title":"The global prevalence of latent tuberculosis: a systematic review and meta-analysis","volume":"54","author":"Cohen","year":"2019","journal-title":"Eur Respir J"},{"key":"10.1016\/j.cmi.2023.07.003_bib2","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1016\/S0140-6736(15)00323-2","article-title":"Controlling the seedbeds of tuberculosis: diagnosis and treatment of tuberculosis infection","volume":"386","author":"Rangaka","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.cmi.2023.07.003_bib3","doi-asserted-by":"crossref","first-page":"E322","DOI":"10.33321\/cdi.2017.41.43","article-title":"Position statement on interferon-\u03b3 release assays for the detection of latent tuberculosis infection","volume":"41","author":"Bastian","year":"2017","journal-title":"Commun Dis Intell Q Rep"},{"key":"10.1016\/j.cmi.2023.07.003_bib4","doi-asserted-by":"crossref","first-page":"125","DOI":"10.33321\/cdi.2012.36.8","article-title":"Position statement on interferon-\u03b3 release assays in the detection of latent tuberculosis infection","volume":"36","author":"Bastian","year":"2012","journal-title":"Commun Dis Intell Q Rep"},{"key":"10.1016\/j.cmi.2023.07.003_bib5","article-title":"Indeterminate results of interferon gamma release assays in the screening of latent tuberculosis infection: a systematic review and meta-analysis","volume":"14","author":"Zhou","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.cmi.2023.07.003_bib6","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1177\/1078345818763868","article-title":"IGRA-based screening for latent tuberculosis infection in persons newly incarcerated in New York City jails","volume":"24","author":"Katyal","year":"2018","journal-title":"J\u00a0Correct Health Care"},{"key":"10.1016\/j.cmi.2023.07.003_bib7","doi-asserted-by":"crossref","first-page":"6468","DOI":"10.1038\/s41598-021-86053-0","article-title":"Low-dose steroids are associated with indeterminate QuantiFERON-TB Gold In-Tube assay results in immunocompetent children","volume":"11","author":"Kim","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.cmi.2023.07.003_bib8","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1093\/jpids\/piu024","article-title":"Relating tuberculosis (TB) contact characteristics to QuantiFERON-TB-Gold and tuberculin skin test results in the Toronto pediatric TB clinic","volume":"4","author":"Rose","year":"2015","journal-title":"J\u00a0Pediatr Infect Dis Soc"},{"key":"10.1016\/j.cmi.2023.07.003_bib9","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1086\/644754","article-title":"Prospective comparison of tuberculin skin test and QuantiFERON-TB Gold In-Tube assay for the detection of latent tuberculosis infection among healthcare workers in a low-incidence setting","volume":"30","author":"Cummings","year":"2009","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.cmi.2023.07.003_bib10","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1136\/flgastro-2017-100951","article-title":"Challenges in screening for latent tuberculosis in inflammatory bowel disease prior to biologic treatment: a UK cohort study","volume":"9","author":"Thi","year":"2018","journal-title":"Frontline Gastroenterol"},{"key":"10.1016\/j.cmi.2023.07.003_bib11","series-title":"Latent tuberculosis infection: a guide for primary Health care providers","year":"2013"},{"key":"10.1016\/j.cmi.2023.07.003_bib12","series-title":"Recommendations on interferon gamma release assays for the diagnosis of latent tuberculosis infection\u20142010 update","year":"2010"},{"key":"10.1016\/j.cmi.2023.07.003_bib13","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/1471-2334-12-107","article-title":"Latent and subclinical tuberculosis in HIV infected patients: a cross-sectional study","volume":"12","author":"Kall","year":"2012","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.cmi.2023.07.003_bib14","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/tid.12489","article-title":"Serial testing for latent tuberculosis infection in transplant candidates: a retrospective review","volume":"18","author":"Roth","year":"2016","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.cmi.2023.07.003_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0042592","article-title":"Predictors and prevalence of latent tuberculosis infection in patients receiving long-term hemodialysis and peritoneal dialysis","volume":"7","author":"Shu","year":"2012","journal-title":"PLOS ONE"},{"key":"10.1016\/j.cmi.2023.07.003_bib16","doi-asserted-by":"crossref","first-page":"ofaa224","DOI":"10.1093\/ofid\/ofaa224","article-title":"A\u00a0targeted screening program for latent tuberculosis infection among hematopoietic cell transplant recipients","volume":"7","author":"Sosa-Moreno","year":"2020","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.cmi.2023.07.003_bib17","doi-asserted-by":"crossref","DOI":"10.1111\/tid.13087","article-title":"High rates of indeterminate interferon-gamma release assays for the diagnosis of latent tuberculosis infection in liver transplantation candidates","volume":"21","author":"Wigg","year":"2019","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.cmi.2023.07.003_bib18","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.5588\/ijtld.11.0017","article-title":"Indeterminate QuantiFERON\u00ae-TB Gold results in a public health clinic setting","volume":"15","author":"Banach","year":"2011","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.cmi.2023.07.003_bib19","doi-asserted-by":"crossref","first-page":"b2700","DOI":"10.1136\/bmj.b2700","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration","volume":"339","author":"Liberati","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.cmi.2023.07.003_bib20","doi-asserted-by":"crossref","first-page":"m549","DOI":"10.1136\/bmj.m549","article-title":"Absolute risk of tuberculosis among untreated populations with a positive tuberculin skin test or interferon-gamma release assay result: systematic review and meta-analysis","volume":"368","author":"Campbell","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.cmi.2023.07.003_bib21","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/S1473-3099(20)30276-0","article-title":"Interferon-\u03b3 release assays or tuberculin skin test for detection and management of latent tuberculosis infection: a systematic review and meta-analysis","volume":"20","author":"Zhou","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cmi.2023.07.003_bib22","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.cmi.2023.07.003_bib23","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.cmi.2023.07.003_bib24","series-title":"Handbook for grading the quality of evidence and the strength of recommendations using the GRADE approach","year":"2013"},{"key":"10.1016\/j.cmi.2023.07.003_bib25","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1093\/infdis\/jit418","article-title":"Reversion and conversion of interferon-\u03b3 release assay results in HIV-1-infected individuals","volume":"209","author":"Aichelburg","year":"2014","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.cmi.2023.07.003_bib26","first-page":"1138","article-title":"Latent tuberculosis infection screening and 2-year outcome in antiretroviral-naive HIV-infected patients in a low-prevalence country","volume":"12","author":"Bourgarit","year":"2015","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.cmi.2023.07.003_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0020770","article-title":"The role of the interferon gamma release assay in assessing recent tuberculosis transmission in a hospital incident","volume":"6","author":"Bradshaw","year":"2011","journal-title":"PLOS ONE"},{"key":"10.1016\/j.cmi.2023.07.003_bib28","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/QAI.0000000000000109","article-title":"Latent tuberculosis screening using interferon-gamma release assays in an Australian HIV-infected cohort: is routine testing worthwhile?","volume":"66","author":"Doyle","year":"2014","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"key":"10.1016\/j.cmi.2023.07.003_bib29","doi-asserted-by":"crossref","DOI":"10.1111\/tid.12675","article-title":"Diagnostic potential of interferon-gamma release assay to detect latent tuberculosis infection in kidney transplant recipients","volume":"19","author":"Edathodu","year":"2017","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.cmi.2023.07.003_bib30","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1007\/s00262-022-03198-1","article-title":"Serial interferon-gamma release assay in lung cancer patients receiving immune checkpoint inhibitors: a prospective cohort study","volume":"71","author":"Fujita","year":"2022","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.cmi.2023.07.003_bib31","doi-asserted-by":"crossref","DOI":"10.1111\/tid.12845","article-title":"Tuberculosis after liver transplantation in a large center in New York City: QuantiFERON\u00ae-TB Gold-based pre-transplant screening performance and active tuberculosis post-transplant","volume":"20","author":"Hand","year":"2018","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.cmi.2023.07.003_bib32","doi-asserted-by":"crossref","DOI":"10.1177\/20406207211028437","article-title":"Features of indeterminate results of QuantiFERON-TB Gold In-Tube test in patients with haematological malignancies","volume":"12","author":"Huang","year":"2021","journal-title":"Ther Adv Hematol"},{"key":"10.1016\/j.cmi.2023.07.003_bib33","article-title":"Management of latent tuberculosis infection based on T-SPOT.TB assay in patients with hematological malignancies","volume":"15","author":"Kilicaslan","year":"2023","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"10.1016\/j.cmi.2023.07.003_bib34","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1111\/j.1600-6143.2011.03625.x","article-title":"A\u00a0prospective longitudinal study evaluating the usefulness of a T-cell-based assay for latent tuberculosis infection in kidney transplant recipients","volume":"11","author":"Kim","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1016\/j.cmi.2023.07.003_bib35","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1089\/aid.2011.0360","article-title":"Predictive value of interferon-\u03b3 ELISPOT assay in HIV 1-infected patients in an intermediate tuberculosis-endemic area","volume":"28","author":"Kim","year":"2012","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1016\/j.cmi.2023.07.003_bib36","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1093\/jac\/dku562","article-title":"Isoniazid treatment to prevent TB in kidney and pancreas transplant recipients based on an interferon-\u03b3-releasing assay: an exploratory randomized controlled trial","volume":"70","author":"Kim","year":"2015","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2023.07.003_bib37","first-page":"403","article-title":"The usefulness of quantitative interferon-gamma releasing assay response for predicting active tuberculosis in kidney transplant recipients: a quasi-experimental study","volume":"81","author":"Kim","year":"2020","journal-title":"J\u00a0Infect"},{"key":"10.1016\/j.cmi.2023.07.003_bib38","doi-asserted-by":"crossref","first-page":"492","DOI":"10.5588\/ijtld.11.0416","article-title":"Development of tuberculosis in immunocompromised patients with a positive tuberculosis-specific IGRA","volume":"16","author":"Lange","year":"2012","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.cmi.2023.07.003_bib39","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/s15010-008-8082-3","article-title":"High prevalence of latent tuberculosis infection in patients in end-stage renal disease on hemodialysis: comparison of QuantiFERON-TB GOLD, ELISPOT, and tuberculin skin test","volume":"37","author":"Lee","year":"2009","journal-title":"Infection"},{"key":"10.1016\/j.cmi.2023.07.003_bib40","first-page":"165","article-title":"A\u00a0prospective longitudinal study evaluating the usefulness of the interferon-gamma releasing assay for predicting active tuberculosis in allogeneic hematopoietic stem cell transplant recipients","volume":"69","author":"Lee","year":"2014","journal-title":"J\u00a0Infect"},{"key":"10.1016\/j.cmi.2023.07.003_bib41","article-title":"A\u00a0clinical algorithm to identify HIV patients at high risk for incident active tuberculosis: a prospective 5-year cohort study","volume":"10","author":"Lee","year":"2015","journal-title":"PLOS ONE"},{"key":"10.1016\/j.cmi.2023.07.003_bib42","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1164\/rccm.201508-1595OC","article-title":"Quantitative IFN-\u03b3 and IL-2 response associated with latent tuberculosis test discordance in HIV-infected pregnant women","volume":"193","author":"Mathad","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.cmi.2023.07.003_bib43","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/j.1399-3062.2012.00765.x","article-title":"Comparison of the QuantiFERON-TB Gold In-Tube test with the tuberculin skin test for detecting latent tuberculosis infection prior to hematopoietic stem cell transplantation","volume":"15","author":"Moon","year":"2013","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.cmi.2023.07.003_bib44","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.1097\/TXD.0000000000000520","article-title":"Immunodiagnostic tests\u2019 predictive values for progression to tuberculosis in transplant recipients: a prospective cohort study","volume":"1","author":"Mu\u00f1oz","year":"2015","journal-title":"Transplant Direct"},{"key":"10.1016\/j.cmi.2023.07.003_bib45","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1093\/cid\/ciaa030","article-title":"Treatment of latent tuberculosis infection based on the interferon-\u03b3 release assay in allogeneic stem cell transplant recipients","volume":"71","author":"Park","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2023.07.003_bib46","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1183\/09031936.06.00110205","article-title":"Use of a T-cell-based test for detection of tuberculosis infection among immunocompromised patients","volume":"28","author":"Piana","year":"2006","journal-title":"Eur Respir J"},{"key":"10.1016\/j.cmi.2023.07.003_bib47","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1164\/rccm.201405-0967OC","article-title":"Risk assessment of tuberculosis in immunocompromised patients. A TBNET study","volume":"190","author":"Sester","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.cmi.2023.07.003_bib48","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000003813","article-title":"Risk of tuberculosis among patients on dialysis: the predictive value of serial interferon-gamma release assay","volume":"95","author":"Shu","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.cmi.2023.07.003_bib49","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1093\/cid\/ciz851","article-title":"Latent tuberculosis infection increases in kidney transplantation recipients compared with transplantation candidates: a neglected perspective in tuberculosis control","volume":"71","author":"Shu","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2023.07.003_bib50","article-title":"Risk of active tuberculosis in HIV-infected patients in Taiwan with free access to HIV care and a positive T-Spot.TB test","volume":"10","author":"Sun","year":"2015","journal-title":"PLOS ONE"},{"key":"10.1016\/j.cmi.2023.07.003_bib51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1399-3062.2011.00666.x","article-title":"Use of the QuantiFERON-TB Gold interferon-gamma release assay for screening transplant candidates: a single-center retrospective study","volume":"14","author":"Theodoropoulos","year":"2012","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.cmi.2023.07.003_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2022.109132","article-title":"Positive rates of interferon-\u03b3 release assay and tuberculin skin test in detection of latent tuberculosis infection: a systematic review and meta-analysis of 200,000 head-to-head comparative tests","volume":"245","author":"Zhou","year":"2022","journal-title":"Clin Immunol"},{"key":"10.1016\/j.cmi.2023.07.003_bib53","first-page":"776","article-title":"Comparison of an interferon-gamma assay with tuberculin skin testing for detection of tuberculosis (TB) infection in patients with rheumatoid arthritis in a TB-endemic population","volume":"35","author":"Ponce de Leon","year":"2008","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.cmi.2023.07.003_bib54","doi-asserted-by":"crossref","first-page":"498","DOI":"10.4103\/ejcdt.ejcdt_194_18","article-title":"Role of QuantiFERON gold assay in the detection and follow-up of treatment of latent tuberculosis infection in some acquired immune-compromised patients","volume":"68","author":"Korra","year":"2019","journal-title":"Egypt J Chest Dis Tuberc"},{"key":"10.1016\/j.cmi.2023.07.003_bib55","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ijid.2019.12.031","article-title":"Latent tuberculosis infection screening in persons newly-diagnosed with HIV infection in Italy: a multicentre study promoted by the Italian Society of Infectious and Tropical Diseases","volume":"92","author":"Goletti","year":"2020","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.cmi.2023.07.003_bib56","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1080\/23744235.2016.1251608","article-title":"Limited usefulness of the interferon-gamma release assay in patients with HIV infections and negative tuberculin skin test results in a country with an intermediate tuberculosis burden","volume":"49","author":"Kim","year":"2017","journal-title":"Infect Dis (Lond)"},{"key":"10.1016\/j.cmi.2023.07.003_bib57","article-title":"Tuberculosis screening in multiple sclerosis: effect of disease-modifying therapies and lymphopenia on the prevalence of indeterminate TB screening results in the clinical setting","volume":"5","author":"Baldassari","year":"2019","journal-title":"Mult Scler J Exp Transl Clin"},{"key":"10.1016\/j.cmi.2023.07.003_bib58","doi-asserted-by":"crossref","first-page":"26","DOI":"10.7224\/1537-2073.2019-015","article-title":"Prevalence of latent tuberculosis in the multiple sclerosis clinic and effect of multiple sclerosis treatment on tuberculosis testing","volume":"23","author":"Bouley","year":"2021","journal-title":"Int J MS Care"},{"key":"10.1016\/j.cmi.2023.07.003_bib59","doi-asserted-by":"crossref","first-page":"e111","DOI":"10.1097\/MPG.0000000000002428","article-title":"Performance of interferon-gamma release assays for tuberculosis screening in pediatric inflammatory bowel disease","volume":"69","author":"Stevens","year":"2019","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.cmi.2023.07.003_bib60","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1093\/ibd\/izx019","article-title":"Indeterminate QuantiFERON-TB Gold increases likelihood of inflammatory bowel disease treatment delay and hospitalization","volume":"24","author":"Vajravelu","year":"2017","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cmi.2023.07.003_bib61","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/ibd.21427","article-title":"Factors impacting the results of interferon-\u03b3 release assay and tuberculin skin test in routine screening for latent tuberculosis in patients with inflammatory bowel diseases","volume":"17","author":"Papay","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cmi.2023.07.003_bib62","series-title":"The handbook of research synthesis","author":"Cooper","year":"1994"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X23003087?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X23003087?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T07:34:39Z","timestamp":1761118479000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X23003087"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":62,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S1198743X23003087"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2023.07.003","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk of progression to active tuberculosis for indeterminate interferon-gamma release assay in immunocompromised individuals: a systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2023.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases.","name":"copyright","label":"Copyright"}]}}